Skip to content
GenoLensGenoLens

PAPSS2

Chr 10q23.2-q23.31

3'-phosphoadenosine 5'-phosphosulfate synthase 2

Aliases:
ATPSK2
MANE:
ENST00000456849.2

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Osteogenesis imperfecta

Disease associations (Open Targets)

  • spondyloepimetaphyseal dysplasia, PAPSS2 type

    0.79
  • Spondyloepimetaphyseal dysplasia, Pakistani type

    0.71
  • hereditary disease

    0.47
  • Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia

    0.46
  • autosomal recessive brachyolmia

    0.45
  • skeletal dysplasia

    0.34
  • urinary tract obstruction

    0.29
  • brachyolmia

    0.28
  • hypothyroidism

    0.27
  • migraine disorder

    0.26

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2

Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate/PAPS, the activated sulfate donor used by sulfotransferases (PubMed:11773860, PubMed:19474428, PubMed:23824674, PubMed:25594860). In mammals, PAPS is the sole source of sulfate while APS appears to only be an intermediate in the sulfate-activation pathway (PubMed:11773860, PubMed:19474428, PubMed:23824674, PubMed:25594860). Plays indirectly an important role in skeletogenesis during postnatal growth (PubMed:9771708)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.